Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 AUD | -10.20% | -24.14% | +91.30% |
Apr. 23 | Pharmaust CEO Resigns | MT |
Apr. 10 | PharmAust Obtains Approval to Commence Monepantel Extension Study | MT |
Sales 2022 | 4.51M 2.92M | Sales 2023 | 3.82M 2.47M | Capitalization | 26.06M 16.87M |
---|---|---|---|---|---|
Net income 2022 | -1M -647K | Net income 2023 | -6M -3.88M | EV / Sales 2022 | 4.69 x |
Net cash position 2022 | 1.03M 670K | Net cash position 2023 | 1.67M 1.08M | EV / Sales 2023 | 6.39 x |
P/E ratio 2022 |
-13
x | P/E ratio 2023 |
-3.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.38% |
1 day | -10.20% | ||
1 week | -24.14% | ||
Current month | -41.33% | ||
1 month | -41.33% | ||
3 months | +37.50% | ||
6 months | +209.86% | ||
Current year | +91.30% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Thurn
CEO | Chief Executive Officer | - | 23-08-31 |
Sam Wright
DFI | Director of Finance/CFO | 46 | 06-08-31 |
Roger Aston
CHM | Chairman | 68 | 13-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Aston
CHM | Chairman | 68 | 13-08-11 |
Sam Wright
DFI | Director of Finance/CFO | 46 | 06-08-31 |
Neville Bassett
BRD | Director/Board Member | - | 18-10-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.22 | -10.20% | 1 791 275 |
24-04-29 | 0.245 | +2.08% | 197,190 |
24-04-26 | 0.24 | -4.00% | 586,133 |
24-04-24 | 0.25 | +6.38% | 1,820,798 |
24-04-23 | 0.235 | -18.97% | 6,945,334 |
Delayed Quote Australian S.E., April 30, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+91.30% | 63.48M | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- PAA Stock